Pd-Rx Pharmaceutical
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing s… Read more
Pd-Rx Pharmaceutical - Asset Resilience Ratio
Pd-Rx Pharmaceutical (PDRX) has an Asset Resilience Ratio of 20.75% as of June 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2019)
This chart shows how Pd-Rx Pharmaceutical's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Pd-Rx Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $2.75 Million | 20.75% |
| Total Liquid Assets | $2.75 Million | 20.75% |
Asset Resilience Insights
- Good Liquidity Position: Pd-Rx Pharmaceutical maintains a healthy 20.75% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Pd-Rx Pharmaceutical Industry Peers by Asset Resilience Ratio
Compare Pd-Rx Pharmaceutical's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Pd-Rx Pharmaceutical (2015–2019)
The table below shows the annual Asset Resilience Ratio data for Pd-Rx Pharmaceutical.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-06-30 | 8.63% | $750.00K | $8.69 Million | -18.90pp |
| 2018-06-30 | 27.53% | $3.50 Million | $12.71 Million | +1.81pp |
| 2017-06-30 | 25.72% | $3.25 Million | $12.63 Million | +4.97pp |
| 2016-06-30 | 20.75% | $2.75 Million | $13.25 Million | +1.96pp |
| 2015-06-30 | 18.80% | $2.25 Million | $11.97 Million | -- |